KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Net Margin (2020 - 2025)

Hims & Hers Health's Net Margin history spans 6 years, with the latest figure at 3.33% for Q4 2025.

  • For Q4 2025, Net Margin fell 207.0% year-over-year to 3.33%; the TTM value through Dec 2025 reached 5.47%, down 307.0%, while the annual FY2025 figure was 5.47%, 307.0% down from the prior year.
  • Net Margin for Q4 2025 was 3.33% at Hims & Hers Health, up from 2.63% in the prior quarter.
  • Across five years, Net Margin topped out at 18.82% in Q3 2024 and bottomed at 98.26% in Q1 2021.
  • The 5-year median for Net Margin is 3.39% (2023), against an average of 9.07%.
  • The largest annual shift saw Net Margin crashed -7819bps in 2021 before it skyrocketed 8222bps in 2022.
  • A 5-year view of Net Margin shows it stood at 36.79% in 2021, then surged by 82bps to 6.52% in 2022, then skyrocketed by 108bps to 0.5% in 2023, then skyrocketed by 971bps to 5.41% in 2024, then plummeted by -38bps to 3.33% in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Net Margin are 3.33% (Q4 2025), 2.63% (Q3 2025), and 7.8% (Q2 2025).